GlassScriptPhysician profile
Ranley Desir
NPI 1629071576
$2,637.29
in general payments reported to CMS, 2019-2025
16 companies · $335 in 2025
The $335 reported for 2025 was more than what a typical provider received nationally.
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2019: $669 · 2020: $212 · 2021: $29.64 · 2022: $347 · 2023: $410 · 2024: $635 · 2025: $335.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Food and Beverage: $1,380.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Food and Beverage | $1,379.70 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Medtronic, INC. | $949.20 | 2022-2025 | Micra, Mycarelink, Aurora Ev-Icd Mri Surescan |
| Abbott Laboratories | $536.48 | 2019-2023 | Aveir |
| Pfizer INC. | $283.36 | 2019-2024 | |
| E.R. Squibb & Sons, L.L.C. | $260.12 | 2019-2025 | Camzyos |
| Heartflow, INC. | $145.96 | 2025 | |
| Boston Scientific Corporation | $115.91 | 2024 | Watchman Flx, Watchman Access System |
| Janssen Pharmaceuticals, INC | $89.93 | 2019-2024 | Xarelto |
| Regeneron Healthcare Solutions, INC. | $55.82 | 2019 | |
| Novartis Pharmaceuticals Corporation | $46.64 | 2019-2024 | |
| Kiniksa Pharmaceuticals International, Plc | $32.16 | 2024 | Arcalyst |
| Kiniksa Pharmaceuticals, LTD. | $28.32 | 2023 | Arcalyst |
| Philips North America LLC | $27.97 | 2024 | (Ck4) Mcot |
| Esperion Therapeutics, INC. | $21.37 | 2024 | Nexletol |
| Sanofi-Aventis U.S. LLC | $20.56 | 2019 | |
| Boehringer Ingelheim Pharmaceuticals, INC. | $16.47 | 2024 | Jardiance |
Show all 16 companies
| Company | General payments | Years | Top products |
|---|---|---|---|
| Ambu INC. | $7.02 | 2021 |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Ranley Desir listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.